235 related articles for article (PubMed ID: 23219861)
1. Efficacy of pimozide augmentation for clozapine partial responders with schizophrenia.
Gunduz-Bruce H; Oliver S; Gueorguieva R; Forselius-Bielen K; D'Souza DC; Zimolo Z; Tek C; Kaliora S; Ray S; Petrides G
Schizophr Res; 2013 Feb; 143(2-3):344-7. PubMed ID: 23219861
[TBL] [Abstract][Full Text] [Related]
2. The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double-blind, placebo-controlled study.
Zoccali R; Muscatello MR; Bruno A; Cambria R; Micò U; Spina E; Meduri M
Schizophr Res; 2007 Jul; 93(1-3):109-16. PubMed ID: 17383857
[TBL] [Abstract][Full Text] [Related]
3. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial.
Josiassen RC; Joseph A; Kohegyi E; Stokes S; Dadvand M; Paing WW; Shaughnessy RA
Am J Psychiatry; 2005 Jan; 162(1):130-6. PubMed ID: 15625211
[TBL] [Abstract][Full Text] [Related]
4. Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment.
Vayısoğlu S; Anıl Yağcıoğlu AE; Yağcıoğlu S; Karahan S; Karcı O; Gürel SC; Yazıcı MK
Schizophr Res; 2013 Jan; 143(1):207-14. PubMed ID: 23217729
[TBL] [Abstract][Full Text] [Related]
5. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of clozapine with ziprasidone in refractory schizophrenia: a double-blind, placebo-controlled study.
Muscatello MR; Pandolfo G; Micò U; Lamberti Castronuovo E; Abenavoli E; Scimeca G; Spina E; Zoccali R; Bruno A
J Clin Psychopharmacol; 2014 Feb; 34(1):129-33. PubMed ID: 24145221
[TBL] [Abstract][Full Text] [Related]
7. Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.
Nielsen J; Emborg C; Gydesen S; Dybbro J; Aagaard J; Haderup K; Glyngdal P; Fabricius S; Thode D; Lublin H; Andersen T; Damkier P; Taylor D
J Clin Psychopharmacol; 2012 Apr; 32(2):173-8. PubMed ID: 22367659
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial.
Chang JS; Ahn YM; Park HJ; Lee KY; Kim SH; Kang UG; Kim YS
J Clin Psychiatry; 2008 May; 69(5):720-31. PubMed ID: 18370574
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study.
Genç Y; Taner E; Candansayar S
Adv Ther; 2007; 24(1):1-13. PubMed ID: 17526456
[TBL] [Abstract][Full Text] [Related]
10. Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy.
Friedman JI; Lindenmayer JP; Alcantara F; Bowler S; Parak M; White L; Iskander A; Parrella M; Adler DN; Tsopelas ND; Tsai WY; Novakovic V; Harvey PD; Davis KL; Kaushik S
Neuropsychopharmacology; 2011 May; 36(6):1289-95. PubMed ID: 21346734
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms.
Kelly DL; Sullivan KM; McEvoy JP; McMahon RP; Wehring HJ; Gold JM; Liu F; Warfel D; Vyas G; Richardson CM; Fischer BA; Keller WR; Koola MM; Feldman SM; Russ JC; Keefe RS; Osing J; Hubzin L; August S; Walker TM; Buchanan RW
J Clin Psychopharmacol; 2015 Aug; 35(4):374-81. PubMed ID: 26082974
[TBL] [Abstract][Full Text] [Related]
12. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
[TBL] [Abstract][Full Text] [Related]
13. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
[TBL] [Abstract][Full Text] [Related]
14. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
Friedman J; Ault K; Powchik P
Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
[No Abstract] [Full Text] [Related]
15. Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
Takeuchi H; Lee J; Fervaha G; Foussias G; Agid O; Remington G
J Clin Psychiatry; 2017 Feb; 78(2):223-228. PubMed ID: 28234436
[TBL] [Abstract][Full Text] [Related]
16. Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
Muscatello MR; Bruno A; Pandolfo G; Micò U; Scimeca G; Di Nardo F; Santoro V; Spina E; Zoccali RA
Schizophr Res; 2011 Apr; 127(1-3):93-9. PubMed ID: 21262565
[TBL] [Abstract][Full Text] [Related]
17. Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial.
Lin CH; Lin CH; Chang YC; Huang YJ; Chen PW; Yang HT; Lane HY
Biol Psychiatry; 2018 Sep; 84(6):422-432. PubMed ID: 29397899
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: results from a 12-week, flexible dose study using raters masked to antipsychotic choice.
Kishi T; Fujita K; Furukawa O; Suzuki T; Moriwaki M; Nitta M; Hattori M; Tsunoka T; Chekuri R; Kane JM; Correll CU; Iwata N
Asian J Psychiatr; 2013 Jun; 6(3):200-7. PubMed ID: 23642976
[TBL] [Abstract][Full Text] [Related]
19. Clozapine alone versus clozapine and risperidone with refractory schizophrenia.
Honer WG; Thornton AE; Chen EY; Chan RC; Wong JO; Bergmann A; Falkai P; Pomarol-Clotet E; McKenna PJ; Stip E; Williams R; MacEwan GW; Wasan K; Procyshyn R;
N Engl J Med; 2006 Feb; 354(5):472-82. PubMed ID: 16452559
[TBL] [Abstract][Full Text] [Related]
20. Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.
Munro J; Matthiasson P; Osborne S; Travis M; Purcell S; Cobb AM; Launer M; Beer MD; Kerwin R
Acta Psychiatr Scand; 2004 Oct; 110(4):292-8. PubMed ID: 15352931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
